ID S35A4_HUMAN Reviewed; 324 AA. AC Q96G79; A8K013; DT 20-MAY-2008, integrated into UniProtKB/Swiss-Prot. DT 01-DEC-2001, sequence version 1. DT 24-JAN-2024, entry version 149. DE RecName: Full=Probable UDP-sugar transporter protein SLC35A4 {ECO:0000305}; DE AltName: Full=Solute carrier family 35 member A4 {ECO:0000312|HGNC:HGNC:20753}; GN Name=SLC35A4 {ECO:0000312|HGNC:HGNC:20753}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Adrenal gland; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Uterus; RX PubMed=17974005; DOI=10.1186/1471-2164-8-399; RA Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., RA Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., RA Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., RA Wiemann S., Schupp I.; RT "The full-ORF clone resource of the German cDNA consortium."; RL BMC Genomics 8:399-399(2007). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Muscle; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP ALTERNATIVE INITIATION (ISOFORM 2). RX PubMed=25621764; DOI=10.7554/elife.03971; RA Andreev D.E., O'Connor P.B., Fahey C., Kenny E.M., Terenin I.M., RA Dmitriev S.E., Cormican P., Morris D.W., Shatsky I.N., Baranov P.V.; RT "Translation of 5' leaders is pervasive in genes resistant to eIF2 RT repression."; RL Elife 4:E03971-E03971(2015). RN [6] RP FUNCTION, SUBCELLULAR LOCATION, TOPOLOGY, AND IDENTIFICATION IN A COMPLEX RP WITH SLC35A2 AND SLC35A3. RX PubMed=28167211; DOI=10.1016/j.bbamcr.2017.02.002; RA Sosicka P., Maszczak-Seneczko D., Bazan B., Shauchuk Y., Kaczmarek B., RA Olczak M.; RT "An insight into the orphan nucleotide sugar transporter SLC35A4."; RL Biochim. Biophys. Acta 1864:825-838(2017). RN [7] RP FUNCTION, AND TRANSPORTER ACTIVITY. RX PubMed=34015330; DOI=10.1016/j.jbc.2021.100789; RA Ury B., Potelle S., Caligiore F., Whorton M.R., Bommer G.T.; RT "The promiscuous binding pocket of SLC35A1 ensures redundant transport of RT CDP-ribitol to the Golgi."; RL J. Biol. Chem. 296:100789-100789(2021). CC -!- FUNCTION: Mediates the transport of CDP-ribitol (PubMed:34015330). Does CC not exhibit CMP-sialic acid, UDP-galactose and UDP-N-acetylglucosamine CC transport activity (PubMed:28167211, PubMed:34015330). CC {ECO:0000269|PubMed:28167211, ECO:0000269|PubMed:34015330}. CC -!- CATALYTIC ACTIVITY: CC Reaction=CDP(out) + CDP-L-ribitol(in) = CDP(in) + CDP-L-ribitol(out); CC Xref=Rhea:RHEA:71579, ChEBI:CHEBI:57608, ChEBI:CHEBI:58069; CC Evidence={ECO:0000269|PubMed:34015330}; CC -!- SUBUNIT: Found in a complex with SLC35A2 and SLC35A3. CC {ECO:0000269|PubMed:28167211}. CC -!- INTERACTION: CC Q96G79; Q13323: BIK; NbExp=3; IntAct=EBI-12363689, EBI-700794; CC Q96G79; P21964: COMT; NbExp=3; IntAct=EBI-12363689, EBI-372265; CC Q96G79; Q7Z7G2: CPLX4; NbExp=3; IntAct=EBI-12363689, EBI-18013275; CC Q96G79; Q96BA8: CREB3L1; NbExp=3; IntAct=EBI-12363689, EBI-6942903; CC Q96G79; P00387: CYB5R3; NbExp=3; IntAct=EBI-12363689, EBI-1046040; CC Q96G79; O00559: EBAG9; NbExp=3; IntAct=EBI-12363689, EBI-8787095; CC Q96G79; Q15125: EBP; NbExp=3; IntAct=EBI-12363689, EBI-3915253; CC Q96G79; Q9Y282: ERGIC3; NbExp=3; IntAct=EBI-12363689, EBI-781551; CC Q96G79; Q5JX71: FAM209A; NbExp=3; IntAct=EBI-12363689, EBI-18304435; CC Q96G79; A2A2Y4: FRMD3; NbExp=3; IntAct=EBI-12363689, EBI-6911547; CC Q96G79; Q9UJ14: GGT7; NbExp=3; IntAct=EBI-12363689, EBI-1058791; CC Q96G79; P48165: GJA8; NbExp=3; IntAct=EBI-12363689, EBI-17458373; CC Q96G79; Q8TDT2: GPR152; NbExp=3; IntAct=EBI-12363689, EBI-13345167; CC Q96G79; Q9BSE4: HERPUD2; NbExp=3; IntAct=EBI-12363689, EBI-2868124; CC Q96G79; Q9NY72: SCN3B; NbExp=3; IntAct=EBI-12363689, EBI-17247926; CC Q96G79; Q96EP9: SLC10A4; NbExp=3; IntAct=EBI-12363689, EBI-17456472; CC Q96G79; Q9UKG4: SLC13A4; NbExp=3; IntAct=EBI-12363689, EBI-12808018; CC Q96G79; Q8WWF3: SSMEM1; NbExp=3; IntAct=EBI-12363689, EBI-17280858; CC Q96G79; Q8N9I0: SYT2; NbExp=3; IntAct=EBI-12363689, EBI-8032987; CC Q96G79; Q9NUH8: TMEM14B; NbExp=3; IntAct=EBI-12363689, EBI-8638294; CC Q96G79; Q6P9G4: TMEM154; NbExp=3; IntAct=EBI-12363689, EBI-13329239; CC Q96G79; Q96Q45-2: TMEM237; NbExp=5; IntAct=EBI-12363689, EBI-10982110; CC Q96G79; Q4KMG9: TMEM52B; NbExp=3; IntAct=EBI-12363689, EBI-18178701; CC Q96G79; Q9BSR8: YIPF4; NbExp=3; IntAct=EBI-12363689, EBI-751253; CC -!- SUBCELLULAR LOCATION: Golgi apparatus membrane CC {ECO:0000269|PubMed:28167211}; Multi-pass membrane protein CC {ECO:0000255}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative initiation; Named isoforms=2; CC Name=1; CC IsoId=Q96G79-1; Sequence=Displayed; CC Name=2; Synonyms=uORF {ECO:0000303|PubMed:25621764}; CC IsoId=L0R6Q1-1; Sequence=External; CC -!- SIMILARITY: Belongs to the nucleotide-sugar transporter family. SLC35A CC subfamily. {ECO:0000305}. CC -!- CAUTION: The translation and the expression of this protein may be CC maintained under stress conditions thanks to the presence of the CC upstream ORF in transcripts. {ECO:0000269|PubMed:25621764}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AK289378; BAF82067.1; -; mRNA. DR EMBL; AL833972; CAD38817.1; -; mRNA. DR EMBL; CH471062; EAW62040.1; -; Genomic_DNA. DR EMBL; BC009906; AAH09906.1; -; mRNA. DR CCDS; CCDS4231.1; -. [Q96G79-1] DR RefSeq; NP_542401.1; NM_080670.3. [Q96G79-1] DR AlphaFoldDB; Q96G79; -. DR SMR; Q96G79; -. DR BioGRID; 125263; 33. DR IntAct; Q96G79; 25. DR MINT; Q96G79; -. DR STRING; 9606.ENSP00000424566; -. DR TCDB; 2.A.7.12.12; the drug/metabolite transporter (dmt) superfamily. DR GlyGen; Q96G79; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; Q96G79; -. DR PhosphoSitePlus; Q96G79; -. DR SwissPalm; Q96G79; -. DR BioMuta; SLC35A4; -. DR DMDM; 74731793; -. DR PaxDb; 9606-ENSP00000424566; -. DR PeptideAtlas; Q96G79; -. DR Antibodypedia; 45451; 28 antibodies from 13 providers. DR DNASU; 113829; -. DR Ensembl; ENST00000323146.8; ENSP00000327133.3; ENSG00000176087.16. [Q96G79-1] DR Ensembl; ENST00000514199.1; ENSP00000424566.1; ENSG00000176087.16. [Q96G79-1] DR Ensembl; ENST00000612662.2; ENSP00000479255.1; ENSG00000176087.16. [Q96G79-1] DR GeneID; 113829; -. DR KEGG; hsa:113829; -. DR MANE-Select; ENST00000323146.8; ENSP00000327133.3; NM_080670.4; NP_542401.1. DR UCSC; uc003lgg.1; human. [Q96G79-1] DR AGR; HGNC:20753; -. DR CTD; 113829; -. DR DisGeNET; 113829; -. DR GeneCards; SLC35A4; -. DR HGNC; HGNC:20753; SLC35A4. DR HPA; ENSG00000176087; Low tissue specificity. DR MIM; 620297; gene. DR neXtProt; NX_Q96G79; -. DR OpenTargets; ENSG00000176087; -. DR PharmGKB; PA134971555; -. DR VEuPathDB; HostDB:ENSG00000176087; -. DR eggNOG; KOG2234; Eukaryota. DR GeneTree; ENSGT00950000182827; -. DR HOGENOM; CLU_024645_5_1_1; -. DR InParanoid; Q96G79; -. DR OMA; SSCVVMI; -. DR OrthoDB; 4641608at2759; -. DR PhylomeDB; Q96G79; -. DR TreeFam; TF315345; -. DR PathwayCommons; Q96G79; -. DR SignaLink; Q96G79; -. DR BioGRID-ORCS; 113829; 11 hits in 1152 CRISPR screens. DR ChiTaRS; SLC35A4; human. DR GenomeRNAi; 113829; -. DR Pharos; Q96G79; Tdark. DR Proteomes; UP000005640; Chromosome 5. DR RNAct; Q96G79; Protein. DR Bgee; ENSG00000176087; Expressed in islet of Langerhans and 180 other cell types or tissues. DR ExpressionAtlas; Q96G79; baseline and differential. DR GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB. DR GO; GO:0000139; C:Golgi membrane; IDA:UniProtKB. DR GO; GO:0015165; F:pyrimidine nucleotide-sugar transmembrane transporter activity; IEA:InterPro. DR GO; GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW. DR InterPro; IPR007271; Nuc_sug_transpt. DR PANTHER; PTHR10231; NUCLEOTIDE-SUGAR TRANSMEMBRANE TRANSPORTER; 1. DR PANTHER; PTHR10231:SF96; UDP-SUGAR TRANSPORTER PROTEIN SLC35A4-RELATED; 1. DR Pfam; PF04142; Nuc_sug_transp; 1. DR PIRSF; PIRSF005799; UDP-gal_transpt; 1. DR SUPFAM; SSF103481; Multidrug resistance efflux transporter EmrE; 1. DR Genevisible; Q96G79; HS. PE 1: Evidence at protein level; KW Alternative initiation; Golgi apparatus; Membrane; Reference proteome; KW Sugar transport; Transmembrane; Transmembrane helix; Transport. FT CHAIN 1..324 FT /note="Probable UDP-sugar transporter protein SLC35A4" FT /id="PRO_0000337748" FT TOPO_DOM 1..18 FT /note="Cytoplasmic" FT /evidence="ECO:0000305|PubMed:28167211" FT TRANSMEM 19..39 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 40..52 FT /note="Lumenal" FT /evidence="ECO:0000305|PubMed:28167211" FT TRANSMEM 53..73 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 74..85 FT /note="Cytoplasmic" FT /evidence="ECO:0000305|PubMed:28167211" FT TRANSMEM 86..106 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 107..142 FT /note="Lumenal" FT /evidence="ECO:0000305|PubMed:28167211" FT TRANSMEM 143..163 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 164..180 FT /note="Cytoplasmic" FT /evidence="ECO:0000305|PubMed:28167211" FT TRANSMEM 181..201 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 202..214 FT /note="Lumenal" FT /evidence="ECO:0000305|PubMed:28167211" FT TRANSMEM 215..235 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 236..250 FT /note="Cytoplasmic" FT /evidence="ECO:0000305|PubMed:28167211" FT TRANSMEM 251..271 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 272..275 FT /note="Lumenal" FT /evidence="ECO:0000305|PubMed:28167211" FT TRANSMEM 276..298 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 299..324 FT /note="Cytoplasmic" FT /evidence="ECO:0000305|PubMed:28167211" FT CONFLICT 79 FT /note="G -> E (in Ref. 1; BAF82067)" FT /evidence="ECO:0000305" FT CONFLICT 81 FT /note="P -> L (in Ref. 1; BAF82067)" FT /evidence="ECO:0000305" FT CONFLICT 306 FT /note="F -> L (in Ref. 1; BAF82067)" FT /evidence="ECO:0000305" SQ SEQUENCE 324 AA; 34593 MW; 9BD54BA459B6C94A CRC64; MSVEDGGMPG LGRPRQARWT LMLLLSTAMY GAHAPLLALC HVDGRVPFRP SSAVLLTELT KLLLCAFSLL VGWQAWPQGP PPWRQAAPFA LSALLYGANN NLVIYLQRYM DPSTYQVLSN LKIGSTAVLY CLCLRHRLSV RQGLALLLLM AAGACYAAGG LQVPGNTLPS PPPAAAASPM PLHITPLGLL LLILYCLISG LSSVYTELLM KRQRLPLALQ NLFLYTFGVL LNLGLHAGGG SGPGLLEGFS GWAALVVLSQ ALNGLLMSAV MKHGSSITRL FVVSCSLVVN AVLSAVLLRL QLTAAFFLAT LLIGLAMRLY YGSR //